Verification evidence is still being completed.
PDF / print export
Diagnostyka S.A.
Krakow, Poland
- Verified lead
- Jakub Swadzba
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Clinical Chemistry, Molecular Diagnostics, Microbiology, and Histopathology at National Scale
- Review cycle
- 24 April 2026
- Full address
- ul. Prof. Michala Zyczkowskiego 16, 31-864 Krakow, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Diagnostyka S.A. About the Group page naming Jakub Swadzba as CEO and Co-founder.
- Editorial note
- Poland's largest medical-diagnostics network with 156 laboratories, over 1,100 patient collection points, WSE listing (DIA), and named co-founder CEO.
Clinical Chemistry, Molecular Diagnostics, Microbiology, and Histopathology at National Scale
WSE listing DIA, Nationwide ISO 15189-aligned network, Public CEO disclosure
Poland's largest medical-diagnostics network with 156 laboratories, over 1,100 patient collection points, WSE listing (DIA), and named co-founder CEO.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Krakow, Poland
Diagnostyka S.A.
Clinical Chemistry, Molecular Diagnostics, Microbiology, and Histopathology at National Scale · National clinical-diagnostic service delivery
Poland's largest medical-diagnostics network with 156 laboratories, over 1,100 patient collection points, WSE listing (DIA), and named co-founder CEO.
- Lead
- Jakub Swadzba (verified ↗)
- Address
- ul. Prof. Michala Zyczkowskiego 16, 31-864 Krakow, Poland (source ↗)
- Compliance
- Nationwide ISO 15189-aligned network
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- National clinical-diagnostic service delivery
- Capabilities
- Nationwide Clinical Laboratory Network · Molecular and Histopathology Diagnostics · B2B and B2C Diagnostic Services
- Founded
- 1998
- Headcount
- 5001-10000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Jakub Swadzba
Chief Executive Officer and Co-Founder
Full addressul. Prof. Michala Zyczkowskiego 16, 31-864 Krakow, Poland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Diag.pl facility page listing Diagnostyka at Zyczkowskiego 16 in Krakow.
Open sourceNational clinical-diagnostic service delivery
Krakow, Poland. Clinical Chemistry, Molecular Diagnostics, Microbiology, and Histopathology at National Scale. Review completed on 24 Apr 2026.
Polish Health Ministry and WSE regulatory oversight
WSE listing DIA, Nationwide ISO 15189-aligned network, Public CEO disclosure
Clinical Chemistry, Molecular Diagnostics, Microbiology, and Histopathology at National Scale
Poland's largest medical-diagnostics network with 156 laboratories, over 1,100 patient collection points, WSE listing (DIA), and named co-founder CEO.
Editorial note
Diagnostyka S.A. is Poland's largest private clinical-diagnostics network with a named co-founder CEO, Warsaw Stock Exchange listing, and a nationwide footprint across clinical chemistry, molecular, microbiology, and histopathology.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Nationwide Clinical Laboratory Network
Molecular and Histopathology Diagnostics
B2B and B2C Diagnostic Services
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Nationwide clinical laboratories
Patient collection points
Molecular diagnostics platforms
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Diagnostyka S.A. located?
- Diagnostyka S.A. operates from ul. Prof. Michala Zyczkowskiego 16, 31-864 Krakow, Poland, Krakow, Poland.
- Who runs Diagnostyka S.A.?
- Diagnostyka S.A. is led by Jakub Swadzba, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What certifications does Diagnostyka S.A. hold?
- Diagnostyka S.A. is documented under Nationwide ISO 15189-aligned network.
- What does Diagnostyka S.A. do?
- Poland's largest medical-diagnostics network with 156 laboratories, over 1,100 patient collection points, WSE listing (DIA), and named co-founder CEO. Core capabilities: Nationwide Clinical Laboratory Network, Molecular and Histopathology Diagnostics, B2B and B2C Diagnostic Services.
Editorial context
Related technical briefs
Briefs that name Krakow as a covered market or city.